Irradiated Whole Human Blood for Immunocompromised Patients from Japan
Gamma-irradiated whole human blood to prevent graft-vs-host disease in transplant or cancer patients, qualifying as therapeutic whole human blood under HTS 3002.90.52.10.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include irradiation dose verification (25-50 Gy) certificates from accredited facilities
• Shortened shelf life post-irradiation (24-28 days); prioritize fastest shipping routes
• Ensure tamper-evident seals and full pedigree tracking to satisfy CBP security requirements